Indications for ACE inhibitors in the early treatment of acute myocardial infarction-Systematic overview of individual data from 100,000 patients in randomized trials

…, L Liu, A Maggioni, P Sleight, K Swedberg, G Tognoni… - Circulation, 1998 - ora.ox.ac.uk
Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic
overview of individual data from 100,000 patients in randomized trials - ORA - Oxford University …

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled …

…, FGR Fowkes, A Zanchetti, MC Roncaglioni, G Tognoni… - The Lancet, 2012 - thelancet.com
Background Daily aspirin reduces the long-term risk of death due to cancer. However, the
short-term effect is less certain, especially in women, effects on cancer incidence are largely …

[HTML][HTML] Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis

…, P Beuret, G Voggenreiter, M Sud, G Tognoni… - Intensive care …, 2010 - Springer
Background Prone position ventilation for acute hypoxemic respiratory failure (AHRF)
improves oxygenation but not survival, except possibly when AHRF is severe. Objective To …

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo …

…, M Santini, C Schweiger, L Tavazzi, G Tognoni… - Circulation, 2002 - Am Heart Assoc
Background—Our purpose was to assess the time course of the benefit of n-3
polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial …

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure

…, E Rucinska, FX Kleber, G Jennings, G Tognoni… - Jama, 1995 - jamanetwork.com
Objective.—To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on
mortality and morbidity in patients with symptomatic congestive heart failure. Data Sources …

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

…, RM Marfisi, AP Maggioni, L Tavazzi, G Tognoni… - The Lancet, 2010 - thelancet.com
Background Trials of statin therapy have had conflicting findings on the risk of development
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …

Genome-wide association study identifies eight loci associated with blood pressure

…, JF Peden, U Seedorf, AC Syvänen, G Tognoni… - Nature …, 2009 - nature.com
Elevated blood pressure is a common, heritable cause of cardiovascular disease worldwide.
To date, identification of common genetic variants influencing blood pressure has proven …

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

…, D Lucci, GL Nicolosi, M Porcu, G Tognoni - Lancet (London …, 2008 - europepmc.org
Background Several epidemiological and experimental studies suggest that n-3
polyunsaturated fatty acids (PUFA) can exert favourable effects on atherothrombotic …

[HTML][HTML] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN Cohn, G Tognoni - New England Journal of Medicine, 2001 - Mass Medical Soc
Background Actions of angiotensin II may contribute to the progression of heart failure
despite treatment with currently recommended drugs. We therefore evaluated the long-term …

[HTML][HTML] Albumin replacement in patients with severe sepsis or septic shock

P Caironi, G Tognoni, S Masson… - … England Journal of …, 2014 - Mass Medical Soc
Background Although previous studies have suggested the potential advantages of albumin
administration in patients with severe sepsis, its efficacy has not been fully established …